US Patent 11123399 Modulators of complement activity
Patent 11123399 was granted and assigned to Ra Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11123399 Modulators of complement activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
